Jw Life Science Corp (234080) - Total Liabilities
Based on the latest financial reports, Jw Life Science Corp (234080) has total liabilities worth ₩95.16 Billion KRW (≈ $64.49 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 234080 operating cash flow to assess how effectively this company generates cash.
Jw Life Science Corp - Total Liabilities Trend (2015–2024)
This chart illustrates how Jw Life Science Corp's total liabilities have evolved over time, based on quarterly financial data. Check how resilient are Jw Life Science Corp's assets to evaluate the company's liquid asset resilience ratio.
Jw Life Science Corp Competitors by Total Liabilities
The table below lists competitors of Jw Life Science Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Champion Microelectronic Corp
TW:3257
|
Taiwan | NT$808.06 Million |
|
Kee Tai Properties Co Ltd
TW:2538
|
Taiwan | NT$12.02 Billion |
|
Century Land Joint Stock Company
VN:CRE
|
Vietnam | ₫1.72 Trillion |
|
Pantech Group Holdings Bhd
KLSE:5125
|
Malaysia | RM310.15 Million |
|
Almogim Holdings Ltd
TA:ALMA
|
Israel | ILA1.46 Billion |
|
Lonyer Fuels
SHG:603003
|
China | CN¥501.56 Million |
|
1-800 FLOWERS.COM Inc
NASDAQ:FLWS
|
USA | $603.36 Million |
Liability Composition Analysis (2015–2024)
This chart breaks down Jw Life Science Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Jw Life Science Corp market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.21 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.44 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.31 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jw Life Science Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jw Life Science Corp (2015–2024)
The table below shows the annual total liabilities of Jw Life Science Corp from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩124.88 Billion ≈ $84.63 Million |
+29.48% |
| 2023-12-31 | ₩96.44 Billion ≈ $65.36 Million |
-14.36% |
| 2022-12-31 | ₩112.61 Billion ≈ $76.31 Million |
+28.00% |
| 2021-12-31 | ₩87.97 Billion ≈ $59.62 Million |
+2.32% |
| 2020-12-31 | ₩85.98 Billion ≈ $58.27 Million |
+9.13% |
| 2019-12-31 | ₩78.79 Billion ≈ $53.39 Million |
-13.99% |
| 2018-12-31 | ₩91.60 Billion ≈ $62.08 Million |
-5.01% |
| 2017-12-31 | ₩96.43 Billion ≈ $65.35 Million |
-5.41% |
| 2016-12-31 | ₩101.94 Billion ≈ $69.08 Million |
+5.04% |
| 2015-12-31 | ₩97.05 Billion ≈ $65.77 Million |
-- |
About Jw Life Science Corp
JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed … Read more